Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Clinical trial NCT04044651 · WITHDRAWN
Trial details
- NCT number
- NCT04044651
- Sponsor
- Shi Ming
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2021-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.